Study Finds Link Between IL-6 and Diabetic Eye Disease
The prospective, single-center study, conducted at the Vanderbilt Eye Institute in Nashville, Tennessee, included 328 eyes of 164 people with diabetes, of whom 23 did not have diabetic retinopathy, 118 had moderate nonproliferative retinopathy, and 23 had proliferative retinopathy, a more severe form of the disease. Eyes without retinopathy had lower levels of IL-6 collected in the aqueous fluid than those with the condition.
A Potential Biomarker
'IL-6 is potentially a biomarker of diabetic eye disease severity and it's a novel target for therapy,' said Stephen J. Kim, MD, chief of the Retina Division at Vanderbilt Eye Institute. 'We can start focusing on inhibiting IL-6; that's the breakthrough, that we now have an inflammatory cytokine that we can use to follow disease, that correlates with disease severity, and we can now inhibit it.'
Stephen J. Kim, MD
Kim and his colleagues published the results of the study, called INSPIRE, on June 27 in Ophthalmology Retina .
The study found that the median level of IL-6 was 5.4 pg/mL (2.99-877) in eyes with no retinopathy, 9.25 pg/mL (5.35-22.35) in eyes with moderate nonproliferative retinopathy, and 15.71 pg/mL (9.24-45.58) in eyes with proliferative disease ( P < .001).
The study also found no difference in median A1c between the three groups ( P = .03). 'There was no correlation between IL-6 and A1c in our study, and that's not surprising because A1c does not correlate very well with risk of progression in diabetic eye disease,' Kim said.
Previous studies implicating IL-6 in diabetic eye disease were small, retrospective studies in which the role of IL-6 was a secondary finding. INSPIRE claims to be the largest analysis of aqueous IL-6 in diabetic eyes.
'The value of this study is that this was a prospective, rigorously assessed, meticulous study,' he said.
A limitation of the study is that it makes two assumptions, Kim said: Aqueous levels of IL-6 are commensurate with levels produced in retina, acting as a surrogate marker; and the study's cross-sectional nature. 'We're not showing a cause and effect that IL-6 levels caused diabetic retinopathy or diabetic macular edema,' Kim said. 'We're just showing a very strong relationships between the two that's suggestive of cause and effect.'
INSPIRE is a 3-year study, and the opportunity exists to demonstrate cause and effect, Kim said.
The finding is 'very practical' because four IL-6 inhibitors are commercially available in the US: tocilizumab (Actemra), indicated for rheumatoid arthritis (RA) and other diseases; sarilumab (Kevzara) for RA; siltuximab (Sylvant) for HIV; and satralizumab (Enspryng) for neuromyelitis optical spectrum disorder. 'This can translate very rapidly,' Kim said.
'This is a potential new treatment to a huge unmet need, and IL-6 may also be a biomarker that we can use to follow not only someone's disease severity but to predict how they will do in 12 months or 24 months,' Kim added.
'Pioneering' Step
Thomas W. Gardner, MD, MS, a professor of ophthalmology and internal medicine at the Kellogg Eye Center at the University of Michigan in Ann Arbor, Michigan, said other studies have shown elevated inflammatory markers in the vitreous or aqueous fluid in both human and experimental models. 'What has been lacking is a prospective, longitudinal study using human samples and correlating those findings with the disease state,' he said. 'This study is important in being pioneering in that step.'
Thomas W. Gardner, MD, MS
Genentech, a subsidiary of Roche, is developing an IL-6 inhibitor, vamikibart, for ophthalmic use, he noted.
While obtaining aqueous fluid from the eye can be 'easy and safe,' Gardner said, handling and processing the samples is fraught with uncertainty. 'How individual ophthalmologists would have those samples analyzed is something that has to be established,' he said. 'But that's a minor issue.'
Gardner called INSPIRE 'a big first step. It isn't necessarily an answer, but it is important for the proof of principal underlying being able to faithfully analyze a molecule such as IL-6 and to incentivize more studies of this type.'
The study was funded by the National Institutes of Health. Kim reported having no relevant financial relationships. Gardner reported having financial relationships with OcularDX and BioCryst.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
ICE goes public with a new report on Canadian man who died in custody
A Canadian who died in ICE custody is documented to have had health concerns, according to a report made public by the U.S. government agency today. While in custody, the 49-year-old was prescribed medication for seizures and hypertension, and recommended to undergo mental health evaluation after he was reported to be feeling 'sad and depressed, and refused to go to the medical clinic for an evaluation.' Here's what we know about the report and the timeline from when Johnny Noviello was arrested and later found dead. Why was the Canadian man arrested by ICE? Johnny Noviello entered the U.S. on a legal visa in 1988 and became a permanent resident in 1991. In 2023, he was convicted on the charges of drug trafficking, racketeering and the unlawful use of two-way communication device used to facilitate commission of crime. He was sentenced to prison for 12 months. His arrest by ICE came in 2025, wherein he was issued a notice to appear in court and faced a removability charge. What does the ICE report say about the health of the Canadian who died in custody? The 49-year-old was pronounced dead late in June after being found unresponsive in a detention centre in Miami. Respecting the family's privacy, Global Affairs minister Anita Anand had said late in June that 'further details will not be provided at this time.' The report released today highlighted health concerns that the officials flagged before he died. Here's what we know about the timeline since his arrest: May 15: Noviello was arrested and detained. May 16: The 49-year-old underwent a routine health inspection. A registered nurse completed the medical intake screening and noted the diagnosis of 'hypertension and seizure disorder, slightly elevated blood pressure, high body mass index, and his reported medication list and sent a provider referral' for him. He was prescribed medication. May 19: A behavioural health provider recommended 'a medical provider evaluate him then refer him to mental health if needed.' May 30: As per the documentation, the Canadian man is said to have refused a health history and a physical exam. June 8: He was reported to be feeling sad and depressed and is said to have refused a health evaluation at a medical clinic. June 9: Noviello reportedly maintained poor personal hygiene and stated he had not eaten in 'a while.' Documentation revealed his vitals to be normal, and that there was discussion with him around the importance of self-hygiene and proper diet. June 23: Noviello was found unresponsive and declared dead. The report by ICE comes as prominent politicians noted the death of the Canadian, and with U.S. ambassador Pete Hoekstra confirming faith in ICE 'commitment to transparency'. 'My team is following the death of a Canadian citizen while in @ICEgov custody. We will keep the Canadian government informed as ICE completes its investigation,' Hoekstra had posted online a few days after Noviello's death. 'I trust in ICE's commitment to transparency and to providing a safe environment for all individuals in its care.' There are 55 Canadians currently in detained by ICE, the agency reported on the figures on July 19. Canadian permanent residents will now have to pay 'visa integrity fee' to enter U.S. Here's what it is Border bitterness is devastating cross-border tourism. But one Canadian city is bucking the trend Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here.
Yahoo
6 minutes ago
- Yahoo
A new genetic test may be able to predict obesity in early childhood. What to know
More than 2 out of 5 adults in the U.S. are considered obese, according to the Centers for Disease Control and Prevention. But what if there was a way to test children to find out if they're at higher risk for contracting the chronic condition while still having time to change their lifestyle? In a study published July 21 in the journal Nature Medicine, more than 600 scientists from 500 institutions worldwide compiled genetic data from more than 5 million people. Using data collected by The Genetic Investigation of ANthropometric Traits (GIANT) consortium – an international collaboration of human genetics researchers and 23andMe – a genetic measure known as polygenic risk scores (PGS) was developed to help identify children at higher risk of developing obesity in adulthood. Obesity is a serious, common and costly chronic condition characterized by excessive body fat, often defined as a Body Mass Index (BMI) of 30 or greater. The American Medical Association considers it a significant public health concern, as it increases the risk of numerous conditions, including diabetes and heart disease. What does the study say? Researchers developed ancestry-specific and multi-ancestry polygenic risk scores and found they were about twice as effective as the risk assessments doctors currently use. For people with European ancestry, the newly developed risk score accounted for about 17.6% of a person's risk of developing a high BMI in adulthood. About 70% of participants whose genetic data was compiled in the study had predominantly European ancestry, 14.4% had Hispanic ethnicity with typically mixed ancestries, 8.4% had predominantly East Asian ancestry, 4.6% had predominantly African ancestry and 1.5% were of predominantly South Asian origin, according to the research. Ruth Loos, a co-author of the study, is a professor at the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen. In an interview with NBC News, she explained, 'Obesity is not only about genetics, so genetics alone can never accurately predict obesity.' 'For the general obesity that we see all over the world, we need other factors, such as lifestyle, that need to be part of the predictions,' added Loos. Obesity increases the risk of nearly 200 diseases and can cause serious health conditions like asthma, strokes, Type 2 diabetes and some types of cancers. It was a risk factor in 3.7 million deaths in 2021. Globally, obesity in adults has more than doubled since 1990, with adolescent rates quadrupling, the World Health Organization reported. How can communities address obesity? Ensuring access to healthy foods, safe places for physical activity, stigma-free obesity prevention and treatment programs, and evidence-based health care services such as medication and surgery are examples of how to address and prevent obesity, according to the CDC. Director of the CDC's National Center for Chronic Disease Prevention and Health Promotion, Karen Hacker previously told USA TODAY that there is no singular approach to addressing the health concern. 'Obesity is a disease caused by many factors, including eating patterns, physical activity levels, sleep routines, genetics and certain medications. This means that there is no one-size-fits-all approach, Hacker said. 'However, we know the key strategies that work include addressing the underlying social determinants of health, such as access to health care, healthy and affordable food and safe places for physical activity,' Hacker added. This article originally appeared on USA TODAY: A new genetic test may be able to predict obesity in early childhood Solve the daily Crossword
Yahoo
6 minutes ago
- Yahoo
Sprains, strains and ACL tears: What to know about some of NFL players' most common injuries
Some of the most important players on NFL teams are those that might not necessarily start the season on the field. Depth is crucial during a rigorous 17-game regular-season schedule that's preceded by a month of training camp practices in hot conditions as players try to make team's 53-man active rosters. Injuries can play as big a role in an NFL team's successes or failures as the best game plans. So being able to navigate injuries and ailments to key players could make all the difference between a team seeing its season sink or making the playoffs. Here's a look at some of the most common injuries suffered by NFL players throughout the season: Achilles tendon tears The Achilles is the longest and strongest tendon in the body and stretches from the heel to the calf. It's a springy band located behind the ankle and just above the heel that helps players push off their feet, jump and accelerate. Due to overuse or excessive force placed on the tendon, it can tear or rupture. Surgery is typically necessary to reconnect the ends, sidelining a player for several months because of the extensive rehabilitation needed. ACL/PCL/MCL/LCL tears The anterior cruciate, posterior cruciate, medial collateral and lateral collateral ligaments are all located in the knee and serve different purposes. The ACL connects the thigh bone to the shin bone in the front of the knee. While a sprain could sideline a player for a few weeks, a tear can end a season. The PCL is located behind the ACL, crisscrossing it to form an "X" in the center of the knee. The MCL connects the thigh bone to the shin bone on the inner side of the knee, while the LCL connects the thigh bone to the top of the lower leg, or fibula, and is located on the outer side of the knee. Concussions A concussion is a brain injury caused by a hit to the head or a sudden movement that causes the head and brain to shake violently. Symptoms may include headaches, neck pain, nausea, dizziness and feeling sluggish. The NFL has been regularly testing and upgrading helmets for players to help reduce the risk of concussions. Eight position-specific helmets for quarterbacks and linemen were approved by the NFL and the NFL Players Association last year. Several players also have worn Guardian Caps, soft, protective helmet covers that the NFL authorized players to use during games last season in an effort to reduce head injuries. Chronic traumatic encephalopathy, or CTE, is a degenerative brain disease that has been linked to concussions and can only be diagnosed posthumously. It can cause memory loss, depression and violent mood swings. Hamstring injuries The hamstring is a group of four muscles that run along the back of the thigh, stretching from the hip to the knee, and they help a person bend their leg at the knee. These injuries vary in severity, and in turn, their timetable in sidelining a player. A mild pull of one of the muscles, commonly referred to as a Grade I injury, can sideline a player for a few days to a couple of weeks and can be a lingering condition if not sufficiently rested and healed. A Grade II hamstring injury involves a partial tear, while a Grade III injury is a complete tear of the hamstring that could require surgery and is likely season-ending. High ankle sprains When a player suffers a high ankle sprain, the ligaments above the ankle — which connect the tibia to the fibula — are affected rather than the ligaments outside the ankle in a low ankle sprain. High ankle sprains take much longer to recover from — six to eight weeks, and sometimes longer — than a classic ankle sprain, which might sideline a player for several days to a couple of weeks. Hip pointers The injury could sideline a player for a week or a couple of months, depending on the severity. A hip pointer is bruising in the pelvis and abdomen area, usually caused by blunt force, such as a hard tackle. The bleeding can affect several other muscles in the area, making it difficult to run or even walk. Lisfranc injuries A serious foot injury that can be career-threatening because of its complexity. A Lisfranc sprain or fracture is an injury in the middle of the foot in which at least one (or sometimes, all) of the small bones (or metatarsals) is broken or the ligaments that support the foot in that area are torn. Even a minor sprain not requiring surgical repair could take six to eight weeks to heal. Meniscus tears The meniscus is a crescent-shaped rubbery disk of cartilage that serves as a shock absorber on the inside and outer edges of the knee. Both help a person balance weight across the knee. When a meniscus is torn, the knee can lock up and swell. A minor tear can be treated with rest, but a severe tear could require surgery that may sideline a player for several weeks or months. Oblique strains An oblique strain involves the muscles on the side of the body between the ribs and pelvis. This type of injury can occur when a player takes a hard hit to the waist area or from overuse or sudden use of the muscles — for instance, a quarterback throwing a pass or a defensive back turning to defend a receiver. Oblique strains are usually treated with rest and could take a few weeks to heal, or could become a lingering issue otherwise. Patellar tendon injuries The patellar tendon allows a person to straighten a leg by acting with the quadriceps. Technically, it's a ligament because it connects the kneecap to the shin bone. Complete tears or ruptures often need to be surgically sewn back together and recovery is typically at least four to six months. Plantar fasciitis An injury that affects the bottom of the foot and can lead to intense heel pain. Plantar fasciitis occurs when the ligament supporting the arch of the foot — the plantar fascia — is strained and worsens when small tears develop in the ligament. The injury can sap players of speed while they deal with it. Rest, icing of the arch and finding new footwear are among typical treatments. It can linger for months. Turf toe An extremely painful injury that can sideline players for months. It occurs when the ligaments under the joint of the big toe are sprained or ruptured as a result of the toe being hyperextended. The injury makes it extremely difficult to push off and cut while running. ___ AP NFL:
